{"uri": "eng-9423388", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Relapse", "type": "wiki", "score": 100, "label": {"eng": "Relapse"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 90, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Neurology", "type": "wiki", "score": 87, "label": {"eng": "Neurology"}}, {"uri": "http://en.wikipedia.org/wiki/Neuromyelitis_optica_spectrum_disorder", "type": "wiki", "score": 75, "label": {"eng": "Neuromyelitis optica spectrum disorder"}}, {"uri": "http://en.wikipedia.org/wiki/Optic_nerve", "type": "wiki", "score": 68, "label": {"eng": "Optic nerve"}}, {"uri": "http://en.wikipedia.org/wiki/Complement_system", "type": "wiki", "score": 67, "label": {"eng": "Complement system"}}, {"uri": "http://en.wikipedia.org/wiki/Enzyme_inhibitor", "type": "wiki", "score": 64, "label": {"eng": "Enzyme inhibitor"}}, {"uri": "http://en.wikipedia.org/wiki/Central_nervous_system", "type": "wiki", "score": 63, "label": {"eng": "Central nervous system"}}, {"uri": "http://en.wikipedia.org/wiki/Phases_of_clinical_research", "type": "wiki", "score": 60, "label": {"eng": "Phases of clinical research"}}, {"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 60, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Vertebral_column", "type": "wiki", "score": 51, "label": {"eng": "Vertebral column"}}, {"uri": "http://en.wikipedia.org/wiki/Clinical_trial", "type": "wiki", "score": 50, "label": {"eng": "Clinical trial"}}, {"uri": "http://en.wikipedia.org/wiki/Efficacy", "type": "wiki", "score": 49, "label": {"eng": "Efficacy"}}, {"uri": "http://en.wikipedia.org/wiki/Cervical_spinal_nerve_5", "type": "wiki", "score": 48, "label": {"eng": "Cervical spinal nerve 5"}}, {"uri": "http://en.wikipedia.org/wiki/Placebo", "type": "wiki", "score": 48, "label": {"eng": "Placebo"}}, {"uri": "http://en.wikipedia.org/wiki/Autoimmune_disease", "type": "wiki", "score": 46, "label": {"eng": "Autoimmune disease"}}, {"uri": "http://en.wikipedia.org/wiki/Disability", "type": "wiki", "score": 44, "label": {"eng": "Disability"}}, {"uri": "http://en.wikipedia.org/wiki/Eculizumab", "type": "wiki", "score": 42, "label": {"eng": "Eculizumab"}}, {"uri": "http://en.wikipedia.org/wiki/Immune_system", "type": "wiki", "score": 38, "label": {"eng": "Immune system"}}, {"uri": "http://en.wikipedia.org/wiki/Rare_disease", "type": "wiki", "score": 36, "label": {"eng": "Rare disease"}}, {"uri": "http://en.wikipedia.org/wiki/Clinical_endpoint", "type": "wiki", "score": 31, "label": {"eng": "Clinical endpoint"}}, {"uri": "http://en.wikipedia.org/wiki/Mayo_Clinic", "type": "org", "score": 28, "label": {"eng": "Mayo Clinic"}}, {"uri": "http://en.wikipedia.org/wiki/United_States", "type": "loc", "score": 24, "label": {"eng": "United States"}, "location": {"type": "country", "label": {"eng": "United States"}}}, {"uri": "http://en.wikipedia.org/wiki/European_Union", "type": "loc", "score": 23, "label": {"eng": "European Union"}, "location": null}], "eventDate": "2024-03-25", "totalArticleCount": 11, "title": {"eng": "FDA Clears Ravulizumab for Neuromyelitis Optica Spectrum Disorder"}, "summary": {"eng": "Receive email when new articles are published on\n\nPain Management\n\nThe US Food and Drug Administration (FDA) has expanded the indication for the long-acting C5 complement inhibitor, ravulizumab (Ultomiris, Alexion), to include adults with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD).\n\nRavulizumab is already approved in the United States to treat adults and children aged 1 or older with paroxysmal nocturnal hemoglobinuria or atypical hemolytic urem"}, "location": null, "categories": [{"uri": "dmoz/Health/Conditions_and_Diseases/Cardiovascular_Disorders", "label": "dmoz/Health/Conditions and Diseases/Cardiovascular Disorders", "wgt": 100}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 65}, {"uri": "news/Health", "label": "news/Health", "wgt": 72}], "articleCounts": {"eng": 11}, "sentiment": 0.05882352941176472, "wgt": 449020800, "relevance": 2}